Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.
Article Details
- CitationCopy to clipboard
Natt E, Kida K, Odievre M, Di Rocco M, Scherer G
Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9297-301.
- PubMed ID
- 1357662 [ View in PubMed]
- Abstract
Tyrosinemia type II (Richner-Hanhart syndrome, RHS) is a disease of autosomal recessive inheritance characterized by keratitis, palmoplantar hyperkeratosis, mental retardation, and elevated blood tyrosine levels. The disease results from deficiency in hepatic tyrosine aminotransferase (TAT; L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5), a 454-amino acid protein encoded by a gene with 12 exons. To identify the causative mutations in five TAT alleles cloned from three RHS patients, chimeric genes constructed from normal and mutant TAT alleles were tested in directing TAT activity in a transient expression assay. DNA sequence analysis of the regions identified as nonfunctional revealed six different point mutations. Three RHS alleles have nonsense mutations at codons 57, 223, and 417, respectively. One "complex" RHS allele carries a GT----GG splice donor mutation in intron 8 together with a Gly----Val substitution at amino acid 362. A new splice acceptor site in intron 2 of the fifth RHS allele leads to a shift in reading frame.